
A recent study challenges the popular belief that time-restricted eating alone improves metabolic health. Without calorie reduction, the…

Compass Pathways’ COMP360 psilocybin formulation reveals promising Phase 3 results for treatment-resistant depression, maintaining remission over six months.

A recent study in JAMA uncovers genetic variants explaining why 10% of patients don’t respond well to GLP-1…

A groundbreaking meta-analysis highlights sleep as a more significant modifiable longevity factor than diet or exercise, reshaping wellness…

A groundbreaking study reveals a new pathway involving hydrogen sulfide that could transform our understanding of Alzheimer’s disease…

Recent research reveals a groundbreaking connection between CSE enzyme activity and Alzheimer’s, spotlighting hydrogen sulfide’s protective role in…

A new Japanese study reveals that preparing a weekly home-cooked meal might lower dementia risk by up to…

The 2026 Breakthrough Prize celebrates leaders in gene therapy and sickle cell research, awarding $3 million each to…

A new study reveals a link between high consumption of fruits and vegetables and increased lung cancer risk…

A novel hormone, FGF21, has shown promise in reversing obesity in mice by activating a brain circuit that…